Cargando…

Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas

BACKGROUND: Transanal endoscopic microsurgery as a local therapy option for rectal neoplasms is a tissue-sparing technique that protects the anal sphincter. The present retrospective analysis reports the course of observation after local excision of adenomas and T1 low-risk carcinomas using transana...

Descripción completa

Detalles Bibliográficos
Autores principales: Amann, Michael, Modabber, Ali, Burghardt, Jens, Stratz, Christian, Falch, Claudius, Buess, Gerhard F, Kirschniak, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556112/
https://www.ncbi.nlm.nih.gov/pubmed/23181563
http://dx.doi.org/10.1186/1477-7819-10-255
_version_ 1782257147711586304
author Amann, Michael
Modabber, Ali
Burghardt, Jens
Stratz, Christian
Falch, Claudius
Buess, Gerhard F
Kirschniak, Andreas
author_facet Amann, Michael
Modabber, Ali
Burghardt, Jens
Stratz, Christian
Falch, Claudius
Buess, Gerhard F
Kirschniak, Andreas
author_sort Amann, Michael
collection PubMed
description BACKGROUND: Transanal endoscopic microsurgery as a local therapy option for rectal neoplasms is a tissue-sparing technique that protects the anal sphincter. The present retrospective analysis reports the course of observation after local excision of adenomas and T1 low-risk carcinomas using transanal endoscopic microsurgery. METHODS: In a retrospective analysis we examined data on 279 patients for local recurrence. A total of 144 patients had a rectal adenoma (n = 103) or a R0 resection of low-risk T1 carcinomas (n = 41). In this collective, we also examined parameters concerning perioperative management, complications, intraoperative blood loss and duration of hospital stay. RESULTS: Patients with adenoma were on average 64.9 (range 37 to 90) years old; 83.5% of the adenomas were located 3 to 11 cm from the anocutaneous line. In adenoma patients the recurrence rate was 2.9% for an observation period of 21.8 months. The postoperative course was without any complications in 98.1% of patients. Patients with T1 low-risk carcinoma were 64.6 (range 30 to 89) years old. In all cases, an R0 resection could be performed. The recurrence rate was 9.8% for an observation period of 34.4 months. In this group the postoperative course was free of complications in 97.6% of patients. CONCLUSIONS: The high efficacy of transanal endoscopic microsurgery ensures minimally invasive treatment of adenomas and low-risk T1 carcinomas with low complication rates and a low rate of therapeutic failure.
format Online
Article
Text
id pubmed-3556112
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35561122013-01-31 Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas Amann, Michael Modabber, Ali Burghardt, Jens Stratz, Christian Falch, Claudius Buess, Gerhard F Kirschniak, Andreas World J Surg Oncol Research BACKGROUND: Transanal endoscopic microsurgery as a local therapy option for rectal neoplasms is a tissue-sparing technique that protects the anal sphincter. The present retrospective analysis reports the course of observation after local excision of adenomas and T1 low-risk carcinomas using transanal endoscopic microsurgery. METHODS: In a retrospective analysis we examined data on 279 patients for local recurrence. A total of 144 patients had a rectal adenoma (n = 103) or a R0 resection of low-risk T1 carcinomas (n = 41). In this collective, we also examined parameters concerning perioperative management, complications, intraoperative blood loss and duration of hospital stay. RESULTS: Patients with adenoma were on average 64.9 (range 37 to 90) years old; 83.5% of the adenomas were located 3 to 11 cm from the anocutaneous line. In adenoma patients the recurrence rate was 2.9% for an observation period of 21.8 months. The postoperative course was without any complications in 98.1% of patients. Patients with T1 low-risk carcinoma were 64.6 (range 30 to 89) years old. In all cases, an R0 resection could be performed. The recurrence rate was 9.8% for an observation period of 34.4 months. In this group the postoperative course was free of complications in 97.6% of patients. CONCLUSIONS: The high efficacy of transanal endoscopic microsurgery ensures minimally invasive treatment of adenomas and low-risk T1 carcinomas with low complication rates and a low rate of therapeutic failure. BioMed Central 2012-11-26 /pmc/articles/PMC3556112/ /pubmed/23181563 http://dx.doi.org/10.1186/1477-7819-10-255 Text en Copyright ©2012 Amann et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Amann, Michael
Modabber, Ali
Burghardt, Jens
Stratz, Christian
Falch, Claudius
Buess, Gerhard F
Kirschniak, Andreas
Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas
title Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas
title_full Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas
title_fullStr Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas
title_full_unstemmed Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas
title_short Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas
title_sort transanal endoscopic microsurgery in treatment of rectal adenomas and t1 low-risk carcinomas
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556112/
https://www.ncbi.nlm.nih.gov/pubmed/23181563
http://dx.doi.org/10.1186/1477-7819-10-255
work_keys_str_mv AT amannmichael transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas
AT modabberali transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas
AT burghardtjens transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas
AT stratzchristian transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas
AT falchclaudius transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas
AT buessgerhardf transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas
AT kirschniakandreas transanalendoscopicmicrosurgeryintreatmentofrectaladenomasandt1lowriskcarcinomas